Darya Vitus1,2, Michelle K Williams1,2, Mehdi Rizk1,2, John K Neubert2,3, Michael Robinson1,2, Jeff Boissoneault1,2. 1. Department of Clinical and Health Psychology, University of Florida, Gainesville, Florida, USA. 2. Center for Pain Research and Behavioral Health, University of Florida, Gainesville, Florida, USA. 3. Department of Orthodontics, University of Florida, Gainesville, Florida, USA.
Abstract
BACKGROUND: Although recent literature provides promising support for the analgesic properties of alcohol, potential differences in alcohol analgesia as a function of chronic pain status are not well understood. Thus, this study examined chronic pain status as a potential moderator of alcohol analgesia and distinguished between multiple aspects of pain experience and sensitivity: pain threshold, pain intensity, pain unpleasantness, and perceived relief. METHODS: Social drinkers with (N = 19) and without (N = 29) chronic jaw pain completed two testing sessions in a counterbalanced order: alcohol (target BrAC = 0.08 g/dl) and placebo. In each, pressure algometry was performed at the insertion of the masseter. Alcohol analgesia was assessed by examining the main and interactive effects of beverage condition, pressure level (4, 5, or 6 pound-feet [lbf]), and chronic jaw pain status (chronic pain vs. pain-free control) on quantitative sensory testing measures and pain relief ratings following noxious stimuli. RESULTS: Analyses indicated significant increases in pain threshold and pain relief and reductions in pain unpleasantness and pain intensity, under the alcohol condition. Chronic pain participants demonstrated lower pain thresholds and greater pain intensity and pain unpleasantness ratings than controls. There were no interactive effects of alcohol and pain conditions on any pain measure. CONCLUSIONS: Findings provide experimental evidence of alcohol's analgesic and pain-relieving effects and suggest that these effects do not significantly differ by chronic pain status. Individuals, who self-medicate pain via alcohol consumption, irrespective of pain status, may be at increased risk to engage in hazardous drinking patterns and thus experience adverse alcohol-related consequences.
BACKGROUND: Although recent literature provides promising support for the analgesic properties of alcohol, potential differences in alcohol analgesia as a function of chronic pain status are not well understood. Thus, this study examined chronic pain status as a potential moderator of alcohol analgesia and distinguished between multiple aspects of pain experience and sensitivity: pain threshold, pain intensity, pain unpleasantness, and perceived relief. METHODS: Social drinkers with (N = 19) and without (N = 29) chronic jaw pain completed two testing sessions in a counterbalanced order: alcohol (target BrAC = 0.08 g/dl) and placebo. In each, pressure algometry was performed at the insertion of the masseter. Alcohol analgesia was assessed by examining the main and interactive effects of beverage condition, pressure level (4, 5, or 6 pound-feet [lbf]), and chronic jaw pain status (chronic pain vs. pain-free control) on quantitative sensory testing measures and pain relief ratings following noxious stimuli. RESULTS: Analyses indicated significant increases in pain threshold and pain relief and reductions in pain unpleasantness and pain intensity, under the alcohol condition. Chronic pain participants demonstrated lower pain thresholds and greater pain intensity and pain unpleasantness ratings than controls. There were no interactive effects of alcohol and pain conditions on any pain measure. CONCLUSIONS: Findings provide experimental evidence of alcohol's analgesic and pain-relieving effects and suggest that these effects do not significantly differ by chronic pain status. Individuals, who self-medicate pain via alcohol consumption, irrespective of pain status, may be at increased risk to engage in hazardous drinking patterns and thus experience adverse alcohol-related consequences.
Authors: Nora D Volkow; Gene-Jack Wang; Dinko Franceschi; Joanna S Fowler; Panayotis Peter K Thanos; Laurence Maynard; S John Gatley; Christopher Wong; Richard L Veech; George Kunos; Ting Kai Li Journal: Neuroimage Date: 2005-08-08 Impact factor: 6.556
Authors: Hedvig Söderlund; Elizabeth S Parker; Barbara L Schwartz; Endel Tulving Journal: Psychopharmacology (Berl) Date: 2005-10-19 Impact factor: 4.530
Authors: A Vania Apkarian; Volker Neugebauer; George Koob; Scott Edwards; Jon D Levine; Luiz Ferrari; Mark Egli; Soundar Regunathan Journal: Pharmacol Biochem Behav Date: 2013-10-02 Impact factor: 3.533
Authors: Adley Tsang; Michael Von Korff; Sing Lee; Jordi Alonso; Elie Karam; Matthias C Angermeyer; Guilherme Luiz Guimaraes Borges; Evelyn J Bromet; K Demytteneare; Giovanni de Girolamo; Ron de Graaf; Oye Gureje; Jean-Pierre Lepine; Josep Maria Haro; Daphna Levinson; Mark A Oakley Browne; Jose Posada-Villa; Soraya Seedat; Makoto Watanabe Journal: J Pain Date: 2008-07-07 Impact factor: 5.820
Authors: Marwan N Baliki; Bogdan Petre; Souraya Torbey; Kristina M Herrmann; Lejian Huang; Thomas J Schnitzer; Howard L Fields; A Vania Apkarian Journal: Nat Neurosci Date: 2012-07-01 Impact factor: 24.884